Noninvasive monitoring of doxorubicin cardiotoxicity: a pilot study of two dogs
| Autor: | Kim A. Selting, J. R. Dodam, M. Garro, J. C. Lattimer, Lisa G. Britt, H. E. Durham, J. W. Skimming, Jeff W. Tyler, James R. Turk, A. W. Spier |
|---|---|
| Rok vydání: | 2004 |
| Předmět: | |
| Zdroj: | Veterinary and Comparative Oncology. 2:107-108 |
| ISSN: | 1476-5829 1476-5810 |
| DOI: | 10.1111/j.1476-5810.2004.0045n.x |
| Popis: | The cardiotoxicity of anthracycline anticancer agents, most notably doxorubicin, limits their use in treating a wide variety of cancers. Currently available methods for assessment of anthracycline-induced cardiotoxicity (AIC) often lack specificity and sensitivity. The purpose of this pilot investigation was to determine noninvasive diagnostic methods that are predictive for AIC. Two mongrel dogs were anesthetized for injection of doxorubicin (22.5 mg) directly into the left coronary artery. Doxorubicin injection was repeated 2 weeks later. Dogs were followed for 12 weeks or until heart failure was documented. Dogs were monitored before and at serial time points after doxorubicin using echocardiography and signal-averaged electrocardiography as well as ambulatory ECG monitoring. Blood was also collected for measurement of cardiac troponin I and T concentrations. Doxorubicin was readministered at 6 and 12 weeks after the second injection, as interim data analysis did not reveal adequate evidence of cardiomyopathy. Dog-1 appeared to be more sensitive than Dog-2 to AIC based upon gradual changes in variables of cardiac function and earlier time to failure (113 days). In contrast, Dog-2 had inconsistent changes in cardiac function and a longer time to failure (139 days). Dog-1 also had greater peak plasma cardiac troponin I levels (17.96 ng/ml) as compared to peak levels in Dog-2 (4.08 ng/ml). In addition, Dog-1 had increased ventricular extrasystolic contractions (VE)(0/day at baseline, 443/day one week prior to death), whereas dog-2 showed very few VE's throughout. Spectral analysis of ECG data also revealed a significant decrease over time in total spectral power in Dog-1 from 37,148 at baseline to 603 msec2/Hz one week prior to death, indicating decreased parasympathetic tone. Endomyocardial biopsies revealed minor changes despite significant clinical abnormalities. These data indicate differences in susceptibility to AIC between Dog-1 and Dog-2, and suggest a role for these noninvasive measures in monitoring the heart during chemotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|